Written by : Aishwarya Sarthe
December 15, 2023
The globally patented test strip detects alcohol content in saliva and indicates whether it surpasses a specified threshold, providing individuals with a quick and accessible way to monitor their alcohol intake.
In a significant development aimed at addressing global health concerns related to alcohol consumption, Goa-based Molbio Diagnostics, has partnered with Finland’s Testi Technologies to launch PROMILLESS, a cost-effective, saliva-based alcohol test.
The collaboration comes in response to the alarming statistics from the World Health Organisation (WHO), revealing that the harmful use of alcohol contributes to 5.1% of the global burden of disease, resulting in 3 million deaths annually.
PROMILLESS, a user-friendly self-test kit developed in partnership with VTT, the Technical Research Centre of Finland, is a CE-approved class 1 device.
The globally patented test strip detects alcohol content in saliva and indicates whether it surpasses a specified threshold, providing individuals with a quick and accessible way to monitor their alcohol intake.
Commenting on the same, Sriram Natarajan, CEO of Molbio Diagnostics, said, "The current alcohol test, alongside upcoming tests like glucose and more in the pipeline, will prove to be a game-changer."
Expanding beyond alcohol testing, Testi Technologies is set to enter the human and pet healthcare markets with a forthcoming saliva-based glucose test. Molbio Diagnostics holds the rights to market and sell PROMILLESS globally under its own brand name through the established agreement.
Molbio Diagnostics, a notable player in the Indian medical technology market, is recognised as the first unicorn catering to global medical professionals. Leveraging Truelab's real-time quantitative micro-PCR system, Molbio offers instant PCR testing in labs worldwide.
In other recent developments, Molbio Diagnostics has collaborated with CrisprBits to launch CRISPR-based point-of-care tests. This partnership signifies a significant stride towards accessible, affordable, and reliable diagnostic testing on the frontline, addressing various diseases and health concerns.
CrisprBits, a biotech start-up, brings forth a platform for quick, accurate, and cost-effective point-of-care tests, leveraging RNA guide-based target identification of nucleic acid and the properties of specific Cas enzymes for enhanced efficiency.
The College of Healthcare Information Management Executives (CHIME) is an executive organization dedicated to serving senior digital health leaders. CHIME includes more than 5,000 members in 56 countries and two US territories and partners with over 150 healthcare IT businesses and professional services firms. CHIME enables its members and business partners to collaborate, exchange ideas, develop professionally and advocate the effective use of information management to improve the health and care throughout the communities they serve. CHIME's members are chief information officers (CIOs), chief medical information officers (CMIOs), chief nursing information officers (CNIOs), chief innovation officers (CIOs), chief digital officers (CDOs), and other senior healthcare leaders. The CHIME India Chapter became the first international chapter outside North America in 2016 and is now a community of over 70+ members in India. For more information, please visit www.chimecentral.org